#AI #DeepLearning #HealthTech #MachineLearning
Good clinical practice, Pharmacology, Clinical research, Health care, Clinical trial protocol, Drug development

Applying AI in Clinical Development of Drugs

On Oct 2, 2020
@Fisher85M shared
RT @pierrepinna: Applying #AI in Clinical Development of Drugs https://t.co/Al147JOvPH v/ @teamrework #HealthTech #MachineLearning #DeepLearning Cc @DeepLearn007 @IrmaRaste @ahier @jblefevre60 @Xbond49 @Nicochan33 @YuHelenYu @Fisher85M @JimMarous https://t.co/NWnzlqebvp
Open

AI is transforming many industries including healthcare and pharma. Where are the opportunities for AI in the early clinical development of new drugs, where scientific hypotheses first meet real patients in clinical trials?

blog.re-work.co
On Oct 2, 2020
@Fisher85M shared
RT @pierrepinna: Applying #AI in Clinical Development of Drugs https://t.co/Al147JOvPH v/ @teamrework #HealthTech #MachineLearning #DeepLearning Cc @DeepLearn007 @IrmaRaste @ahier @jblefevre60 @Xbond49 @Nicochan33 @YuHelenYu @Fisher85M @JimMarous https://t.co/NWnzlqebvp
Open

Applying AI in Clinical Development of Drugs

Applying AI in Clinical Development of Drugs

AI is transforming many industries including healthcare and pharma. Where are the opportunities for AI in the early clinical development of new drugs, where scientific hypotheses first meet ...

Otsuka: Real-Time Data Changes Trial Paradigm

Otsuka: Real-Time Data Changes Trial Paradigm

As the Otsuka VP of Applied Innovation and Process Improvement, Debbie Profit spends a lot of her time thinking about the future of clinical trials.

AI is going to transform the pharmaceutical industry. Here's how.

AI is going to transform the pharmaceutical industry. Here's how.

From lowering risk during drug trials to better study design and faster results, Big Data, the cloud, and AI are transforming how medicine gets made.

Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller

Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to ...

Can Algorithms Diagnose Disease Better Than Doctors?

Can Algorithms Diagnose Disease Better Than Doctors?

AI holds great promise for medical diagnoses. But researchers warn it takes careful methodology and strong regulation to boost patient outcomes.

10 Interesting Clinical Research Podcasts to Listen To

10 Interesting Clinical Research Podcasts to Listen To

From growing a career in clinical research to the latest fascinating innovations in biotech, these clinical research podcasts can keep you informed and teach you something new.

SOTIO Opens Office in Basel, Switzerland, to Accelerate Development of its Pipeline Products

SOTIO Opens Office in Basel, Switzerland, to Accelerate Development of its Pipeline Products

PRAGUE, Czech Republic, January 08, 2020 / B3C newswire / -- SOTIO, a biotechnology company owned by the PPF Group, announce today the opening of offices of SOTIO Biotech AG at the ...

Clinical trials are smartening up to the potential of AI

Clinical trials are smartening up to the potential of AI

The application of AI and ML techniques to the pharmaceutical industry would have impact to improve R&D productivity and sustaining the current pace of innovation.

Estimation of clinical trial success rates and related parameters

Estimation of clinical trial success rates and related parameters

SUMMARY. Previous estimates of drug development success rates rely on relatively small samples from databases curated by the pharmaceutical industry and are su

ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial

ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial

Study to identify genomic markers associated with clinical response to ADCT-402 (loncastuximab tesirine) inrelapsed or refractory diffuse large B-cell lymphoma (DLBCL) Lausanne, ...